Effectiveness of acceptance and commitment therapy (ACT) on depression and sleep quality in painful diabetic neuropathy: a randomized clinical trial.
Acceptance and commitment therapy
Depression
Diabetes mellitus
Neuropathy
Pain
Sleep
Journal
Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
09
05
2020
accepted:
07
07
2020
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
epublish
Résumé
Neuropathic pain is a complicated phenomenon in patients with diabetes. These patients have many problems, especially depression and Sleep disturbance. This study aimed to assess the effectiveness of Acceptance and Commitment Therapy on depression and Sleep disturbance in patients with painful diabetic neuropathy. The current paper was conducted according to the clinical trial method with 50 participants. Participants were separated into intervention and control groups randomly. Based on the diagnosis of neurologists, all participants received standard medications to regulate neuropathic pain. The intervention group received ACT for eight sessions. The results were evaluated in the pre-test, post-test, and follow-up. The tools used were the Pittsburgh sleep quality index (PSQI) and Beck's depression inventory. Statistical analysis includes descriptive statistics, and repeated-measures (ANOVA) conducted by SPSS (version 26) software. Results: Results showed that in the intervention group, the treatment led to improved depressive symptoms (F = 6.81, ACT, as a complementary treatment, can improve the psychiatric symptoms and problems in people with neuropathic pain. Therefore, it is necessary to include psychotherapy services along with medical treatment in outpatient and hospitalization units. IRCT201802050388630N4. Registered in 02/05/2018.
Sections du résumé
BACKGROUND
BACKGROUND
Neuropathic pain is a complicated phenomenon in patients with diabetes. These patients have many problems, especially depression and Sleep disturbance. This study aimed to assess the effectiveness of Acceptance and Commitment Therapy on depression and Sleep disturbance in patients with painful diabetic neuropathy.
METHODS
METHODS
The current paper was conducted according to the clinical trial method with 50 participants. Participants were separated into intervention and control groups randomly. Based on the diagnosis of neurologists, all participants received standard medications to regulate neuropathic pain. The intervention group received ACT for eight sessions. The results were evaluated in the pre-test, post-test, and follow-up. The tools used were the Pittsburgh sleep quality index (PSQI) and Beck's depression inventory. Statistical analysis includes descriptive statistics, and repeated-measures (ANOVA) conducted by SPSS (version 26) software. Results: Results showed that in the intervention group, the treatment led to improved depressive symptoms (F = 6.81,
CONCLUSION
CONCLUSIONS
ACT, as a complementary treatment, can improve the psychiatric symptoms and problems in people with neuropathic pain. Therefore, it is necessary to include psychotherapy services along with medical treatment in outpatient and hospitalization units.
TRIAL REGISTRATION NUMBER
BACKGROUND
IRCT201802050388630N4. Registered in 02/05/2018.
Identifiants
pubmed: 33520825
doi: 10.1007/s40200-020-00609-x
pii: 609
pmc: PMC7843707
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1081-1088Informations de copyright
© Springer Nature Switzerland AG 2020.
Déclaration de conflit d'intérêts
Conflict of interestThe authors report no conflicts of interest in this project.
Références
Iran J Pediatr. 2015 Aug;25(4):e2436
pubmed: 26396702
Curr Aging Sci. 2019;12(1):62-66
pubmed: 31589113
Behav Res Ther. 2012 Nov;50(11):651-60
pubmed: 22975073
Curr Neuropharmacol. 2021;19(1):78-91
pubmed: 32148197
J Consult Clin Psychol. 2007 Apr;75(2):336-43
pubmed: 17469891
Addict Health. 2017 Jul;9(3):129-138
pubmed: 29657693
Diabetes Res Clin Pract. 2020 Mar;161:108035
pubmed: 32006640
Diabet Med. 2012 Jan;29(1):140-7
pubmed: 21988640
Pain Med. 2011 Jun;12(6):904-12
pubmed: 21539701
Pain Ther. 2017 Dec;6(Suppl 1):11-17
pubmed: 29178035
Endocrinol Metab Clin North Am. 2013 Sep;42(3):529-44
pubmed: 24011885
Sleep Breath. 2012 Mar;16(1):79-82
pubmed: 21614577
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
BMC Nurs. 2015 Nov 19;14:61
pubmed: 26594131
BMJ Open. 2018 Nov 28;8(11):e022234
pubmed: 30498037
Psychother Psychosom. 2014;83(6):371-3
pubmed: 25323449
J Affect Disord. 2020 Feb 15;263:107-120
pubmed: 31818766
Community Ment Health J. 2015 Feb;51(2):204-10
pubmed: 24951962